Drug Profile
Research programme: saccharide foam - Foamix
Latest Information Update: 16 Mar 2020
Price :
$50
*
At a glance
- Originator Foamix
- Class Carbohydrates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Burns; Wounds
Most Recent Events
- 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics